Centene Corp. (CNC) and Laboratory Corp. of America Holdings (LH) were among the healthcare stocks in the green on Tuesday, Feb. 6, amid a volatile trading day in the stock market. The Dow Jones industrial average ended the trading session up 567 points, or 2.3%, after a day of wild swings. The S&P 500 index finished with a gain of 46.2 points, or 1.7%.

Shares of Centene closed up 4.3% at $103.67, and LabCorp finished at $168.67, up 2.5%.

St. Louis-based Centene on Tuesday reported fourth-quarter adjusted diluted earnings per share of 97 cents on revenue of $12.81 billion. Analysts had projected, on average, adjusted EPS of 93 cents on revenue of $12.25 billion, according to Bloomberg. Centene also raised its 2018 guidance.

LabCorp, based in Burlington, N.C., reported adjusted EPS of $2.45 on net revenue of $2.8 billion for the fourth quarter. Analysts expected adjusted EPS of $2.38 on revenue of $2.7 billion.

Among the other gainers was Gilead Sciences Inc. (GILD) , which closed at $80.38, up 2.6%.

After the market close on Tuesday, the Foster City, Calif., company reported fourth-quarter non-GAAP net income per share of $1.78 on revenue of $5.9 billion. Analysts expected adjusted EPS of $1.67 on revenue of $5.71 billion.

For its part, shares of Allergan plc (AGN) finished at $168.33, up 2%. The Dublin drugmaker on Tuesday morning reported fourth-quarter non-GAAP net income per share of $4.86 on net revenue of $4.33 billion. Analysts expected, on average, adjusted EPS of $4.74 on revenue of $4.28 billion, according to FactSet Research Systems Inc.

Allergan also unveiled positive results from a clinical trial of ubrogepant for migraine treatment.

Meanwhile, shares of Merck & Co. (MRK) closed at $55.46, down 1.7%. Shares of Varian Medical Systems Inc. (VAR) ended the session down 0.9% to $118.58.

Allergan is a holding in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio. Want to be alerted before Cramer and the AAP team buy or sell AGN? Learn more now.

More from Stocks

3 Profitable Small Biotech Names to Consider

3 Profitable Small Biotech Names to Consider

Tech Stock Predictions for 2019

Tech Stock Predictions for 2019

Nutrisystem Soars on Deal to Be Acquired by Tivity Health

Nutrisystem Soars on Deal to Be Acquired by Tivity Health

Jim Cramer Says That This Is a Question All Investors Must Ask Themselves

Jim Cramer Says That This Is a Question All Investors Must Ask Themselves

Elon Musk, Carlos Ghosn, Huawei and Gilead Sciences - 5 Things You Must Know

Elon Musk, Carlos Ghosn, Huawei and Gilead Sciences - 5 Things You Must Know